Document Detail

Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  21052009     Owner:  NLM     Status:  In-Process    
The aim of this study was to investigate the relationship between late gadolinium enhancement (LGE) and the effect of cibenzoline (CBZ) on left ventricular (LV) diastolic function in hypertrophic cardiomyopathy (HCM) patients. Echocardiography before and after intravenous CBZ (1.4 mg/kg over 5 minutes) and magnetic resonance imaging (MRI) were performed in 22 consecutive patients with HCM [mean age: 65 ± 14 years, obstructive HCM: 14, nonobstructive HCM (HNCM): 8]. The extent of LGE (%LGE = LGE volume/total LV volume) was obtained by contrast-enhanced MRI using custom software. LGE was observed in 19 patients (mean %LGE = 5.1% ± 3.9%). The propagation velocity of LV early filling flow (Vp) increased significantly in patients with obstructive HCM (26 ± 7 to 36 ± 14 cm/s, P = 0.001) and nonobstructive HCM (25 ± 9 to 36 ± 16 cm/s, P = 0.007). A significant negative correlation was observed between the change in Vp and %LGE in patients with HCM (r = 20.542, P = 0.009). Less extensive myocardial fibrosis, as demonstrated by LGE on contrast-enhanced MRI, may predict the ability of CBZ to improve LV diastolic function in HCM.
Makoto Saito; Hideki Okayama; Toyofumi Yoshii; Go Hiasa; Takumi Sumimoto; Shinji Inaba; Kazuhisa Nishimura; Katsuji Inoue; Akiyoshi Ogimoto; Yuji Shigematsu; Jun-ichi Funada; Mareomi Hamada; Jitsuo Higaki
Related Documents :
16449509 - Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgit...
11290859 - A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography.
17302719 - Segmental wall motion abnormality analyzed by equilibrium radionuclide angiography and ...
630679 - Accuracy of echocardiography in assessing left ventricular dimensions and volume.
12754029 - Determinants of long-term mortality of current palliative surgical treatment for dilate...
17347039 - Clinical diagnosis of left ventricular dilatation and dysfunction in the age of technol...
24460869 - Extracellular matrix remodeling following myocardial infarction influences the therapeu...
1124719 - Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate...
8780929 - The myocardial fibrosis in patients with dilated cardiomyopathy. the application of ima...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  57     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-05-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  207-12     Citation Subset:  IM    
Department of Cardiology, Kitaishikai Hospital, Ozu, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, a...
Next Document:  Effects of fondaparinux and a direct factor Xa inhibitor TAK-442 on platelet-associated prothrombina...